JANE STREET GROUP, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 34 filers reported holding SEELOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,995
-36.7%
43,451
+137.7%
0.00%
Q1 2023$12,637
-25.7%
18,283
-26.7%
0.00%
Q2 2022$17,000
-39.3%
24,951
-25.4%
0.00%
Q1 2022$28,000
-81.0%
33,460
-63.1%
0.00%
Q4 2021$147,000
-68.7%
90,775
-53.3%
0.00%
Q3 2021$469,000
-18.9%
194,300
-11.2%
0.00%
Q2 2021$578,000
-76.6%
218,884
-55.7%
0.00%
-100.0%
Q1 2021$2,466,000
+10621.7%
494,135
+3240.6%
0.00%
Q4 2020$23,000
+91.7%
14,792
+25.6%
0.00%
Q2 2020$12,000
-92.9%
11,777
-76.5%
0.00%
Q1 2019$168,00050,1000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders